Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2024; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
MED INVEST from Kontich, company number BE0886494777, closed financial year 2024 with a result of € -2,944 after tax. For that financial year MED INVEST recorded a gross margin of € -1,952 and equity of € -23,995. Compared with financial year 2023, the result moved from € -4,264 to € -2,944. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.
€ -23,995
▼ € 2,944 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2,944
▲ 31 % less loss than in 2023
Profit after tax over the fiscal year.
€ 244
▲ € 240 vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -42,595.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 2,118
▲ 43% vs 2023
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -1,837 | € -2,064 | € -2,904 | € -1,952 | ▲ € 952 |
| Profit after taxes | € -2,793 | € -2,926 | € -4,264 | € -2,944 | ▲ € 1,320 |
| Equity | € -13,861 | € -16,786 | € -21,050 | € -23,995 | ▼ € 2,944 |
| Total debts | € 13,900 | € 16,882 | € 21,293 | € 24,381 | ▲ 15% |
| Cash | € 5 | € 57 | € 4 | € 244 | ▲ € 240 |
| Retained profit | € -32,461 | € -35,386 | € -39,650 | € -42,595 | ▼ € 2,944 |
| Balance sheet total | € 39 | € 96 | € 242 | € 386 | ▲ 59% |
Key figures of MED INVEST, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to MED INVEST?
What happened at MED INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 2,944. filed late Source: NBB ↗
- New establishment in Kontich. KBO
- Start of the company according to the CBE. KBO
- Dirk Stockman became a director. NBB
In short
From € 2,793 loss in 2021 to € 2,944 loss in 2024.
A new publication or filing at MED INVEST? We notify you, reason included.
Follow MED INVESTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DR. STOCKMAN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MED INVESTBehind MED INVEST is Dirk Stockman. The shares are held by DR. STOCKMAN (40.9%).
Directors
According to the 2024 annual accounts
Dirk Stockman
Director
since 2007
Shareholders
40.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Koningin Astridlaan 47 box B
2550 Kontich
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0886.494.777
- VAT number
- BE 0886.494.777
- Registered office
- Koningin Astridlaan 47 bus B, 2550 Kontich
- Names & denominations
- MED INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 January 2007
- Peppol
- Not registered